Wp Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Wp Advisors, LLC

$273 Million
Q3 2024

A detailed history of Wp Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wp Advisors, LLC holds 3,199 shares of VRTX stock, worth $1.28 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

3,199

Previous 4,044 20.9%

Holding current value

$1.28 Million

Previous $1.9 Million 21.53%

% of portfolio

0.54%

Previous 0.6%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$460.0 - $505.78 $388,700 - $427,384	-845 Reduced 20.9%	3,199 $1.49 Million
Q2 2024 Jul 30, 2024	SELL	$392.81 - $485.53 $39,281 - $48,553	-100 Reduced 2.41%	4,044 $1.9 Million
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $28,538 - $31,225	-70 Reduced 1.66%	4,144 $1.73 Million
Q4 2023 Jan 31, 2024	SELL	$343.0 - $410.68 $115,591 - $138,399	-337 Reduced 7.4%	4,214 $1.71 Million
Q3 2023 Oct 30, 2023	SELL	$338.18 - $362.46 $11,498 - $12,323	-34 Reduced 0.74%	4,551 $1.58 Million
Q2 2023 Jul 26, 2023	SELL	$314.42 - $351.91 $131,113 - $146,746	-417 Reduced 8.34%	4,585 $1.61 Million
Q4 2022 Jan 20, 2023	SELL	$285.76 - $321.48 $201,460 - $226,643	-705 Reduced 12.35%	5,002 $0
Q3 2022 Oct 24, 2022	BUY	$273.83 - $305.53 $4,928 - $5,499	18 Added 0.32%	5,707 $1.65 Million
Q1 2022 Apr 25, 2022	SELL	$221.42 - $260.97 $11,071 - $13,048	-50 Reduced 0.87%	5,689 $1.49 Million
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $130,633 - $164,906	-738 Reduced 11.39%	5,739 $1.26 Million
Q3 2021 Oct 20, 2021	BUY	$181.39 - $202.99 $544,532 - $609,375	3,002 Added 86.39%	6,477 $1.18 Million
Q2 2021 Jul 22, 2021	BUY	$187.49 - $221.1 $47,247 - $55,717	252 Added 7.82%	3,475 $701,000
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $275,957 - $321,666	1,333 Added 70.53%	3,223 $693,000
Q4 2020 Jan 27, 2021	BUY	$207.01 - $276.09 $391,248 - $521,810	1,890 New	1,890 $447,000
Q3 2018 Oct 31, 2018	SELL	$167.73 - $192.74 $8,386 - $9,637	-50 Closed	0 $0
Q2 2018 Jul 27, 2018	BUY	$145.72 - $169.96 $7,286 - $8,498	50 New	50 $8,000

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wp Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wp Advisors, LLC with notifications on news.

Account